BREAKTHROUGH: A Biocatalyst that runs for 20,000+ hours

HydGene Head of Engineering Peter Meek has released the latest article in his LinkedIn series - exploring one of the core breakthroughs underpinning HydGene’s platform technology.

In industrial biotechnology, long-term continuous operation is one of the sector’s biggest unsolved challenges. Living biological systems are powerful, but they are also fragile — vulnerable to contamination, instability, and performance degradation over time.

In his latest article, BREAKTHROUGH: A Biocatalyst that runs for 20,000+ hours, Peter explains how HydGene approached this challenge differently.

HydGene has developed a proprietary immobilised biocatalyst platform capable of operating continuously for more than two years from the same unit — without replacement, poisoning, or meaningful degradation. The breakthrough fundamentally changes how biological systems can perform in industrial environments.

The article explores:

• why conventional fermentation systems struggle to scale reliably

• how HydGene separates biology from catalysis

• why immobilisation changes feedstock flexibility and system stability

• and what this means for the future of decentralised chemical manufacturing

  
  

As Peter explains: “We’re not asking operators to trust or manage living biology with its inherent variability. We’re offering something that behaves more like industrial hardware — robust, predictable, and designed to keep running.”

This breakthrough forms part of HydGene’s broader mission to redefine how hydrogen and essential chemicals are manufactured — using low-cost biomass feedstocks and modular on-site systems.

Peter's series will continue weekly on LinkedIn. Follow Peter Meek and HydGene Renewables to stay across the conversation.